Andreas Josefsson
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Correction: Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.
Journal: Scientific reports
Published: July 15, 2026
MicroRNA profiles of prostate cancer bone metastases and miR-375 as an inhibitor of the aggressive metastasis subtype MetB.
Journal: Scientific reports
Published: January 29, 2026
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095.
Journal: BMC cancer
Published: January 21, 2026
Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.
Journal: Scientific reports
Published: January 14, 2026
SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer.
Journal: Acta oncologica (Stockholm, Sweden)
Published: December 04, 2025
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform.
Journal: European urology focus
Published: May 25, 2025
Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis.
Journal: Clinical & experimental metastasis
Published: April 10, 2025
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Andreas Josefsson, Marianne Månsson, Kimia Kohestani, et al. Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. Eur Urol 2024;86:223-9.
Journal: European urology
Published: February 20, 2025
Neonatal Outcomes Among Infants of Mothers With Advanced Maternal Age: A National Cohort Study.
Journal: Acta paediatrica (Oslo, Norway : 1992)
Published: January 14, 2025
Effects of a Phytoestrogen Intervention and Estrogen Receptor β Genotype on Prostate Cancer Proliferation and PSA Concentrations-A Randomized Controlled Trial.
Journal: Nutrition and cancer
Published: September 28, 2024
Clinical cell-surface targets in metastatic and primary solid cancers.
Journal: JCI insight
Published: September 24, 2024
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancer.
Journal: Molecular oncology
Published: July 04, 2024
Last Updated: 09/26/2026